Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SAGE - Sage Therapeutics Could Be In For A Depressing FDA Review

SAGE - Sage Therapeutics Could Be In For A Depressing FDA Review

Sage Therapeutics Inc.

Summary

  • Sage Therapeutics, Inc. completed its rolling submission to the FDA for zuranolone in two indications.
  • Zuranolone is a better formulation of Sage Therapeutics' marketed postpartum drug.
  • However, clinical experience on the major depression side is shaky.

For further details see:

Sage Therapeutics Could Be In For A Depressing FDA Review
Stock Information
Company Name: Sage Therapeutics Inc.
Stock Symbol: SAGE
Market: NASDAQ
Website: sagerx.com
Menu
SAGE SAGE Quote SAGE Short SAGE News SAGE Articles SAGE Message Board
Get SAGE Alerts

News, Short Squeeze, Breakout and More Instantly...